Accurate Suicide Risk Detection With eC-SSRS Helps Ensure Safety of Trial Participants and Treatments in Oncology and Beyond Webinar Replay

Protecting patients, compounds and proving benefits: How accurately accessing suicide risk detection with eC-SSRS/C-SSRS helps ensure clinical trial participants and their treatments remain safe in oncology and beyond.

Join esteemed speakers, Dr. Kelly Posner, Dr. John Greist and Libby Thomas for a deep dive into the nuances of accurately assessing suicide risk, including how the Columbia-Suicide Severity Rating Scale (Clinician reported: C-SSRS, patient self-report: eC-SSRS) is benefiting clinical trials by protecting patients, protecting drug compounds and more.